Compare Royalty Pharma plc Class A Ordinary Shares (RPRX) vs Viasat (VSAT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Royalty Pharma plc Class A Ordinary Shares vs Viasat — how do they compare? Royalty Pharma plc Class A Ordinary Shares trades at $56.2 (market cap $25.27B), while Viasat trades at $69.24 (market cap $9.76B). The key difference: Royalty Pharma plc Class A Ordinary Shares is far larger — about 2.6× Viasat's market cap, and Royalty Pharma plc Class A Ordinary Shares pays a 1.66% dividend while Viasat pays none. Which is the better fit depends on your goals — on Pluang, investors hold Royalty Pharma plc Class A Ordinary Shares for 0 Days and Viasat for 10 Days on average.
| RPRX | VSAT | |
|---|---|---|
Market Cap | $25.27B | $9.76B |
Volume | 3,671,183 | 1,739,997 |
Sector | Health | Technology |
52-Week High | $63.96 | $89.81 |
52-Week Low | $35.44 | $30.35 |
Typical Hold Time | 0 Days | 10 Days |
Enterprise Value | $32.50B | $14.95B |
Dividend Yield | 1.66% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →About Viasat
Viasat provides satellite communications and connectivity services for aviation, maritime, government, enterprise, and consumer markets. Its network combines satellite and ground infrastructure to deliver connectivity in remote and mobile environments.
Read more on VSAT →
